Osteopathic manipulative therapy decreased postpartum low back pain by over 70 percent in women who had given birth at least three months before beginning treatment, according to a new study.
A technique to increase the flow of blood from the umbilical cord into the infant’s circulatory system improves blood pressure and red blood cell levels in preterm infants delivered by Cesarean section, according to a study.
The Royal College of Obstetricians and Gynaecologists (RCOG) has pledged to improve patient safety as part of the national campaign, Sign up to Safety.
Pelvic girdle pain affects one in five pregnant women and can severely affect a woman’s mobility and quality of life. Early diagnosis and treatment should relieve pain and prevent symptoms from worsening, states new Patient Information published today by the Royal College of Obstetricians and Gynaecologists (RCOG).
Women who have experienced a stillbirth have up to a fourfold increased risk of stillbirth in a second pregnancy compared to those who had an initial live birth, finds a new meta-analysis.
The initial results of a study suggested that children born by Cesarean section were 21 percent more likely to be diagnosed with autism spectrum disorder but that association did not hold up in further analysis of sibling pairs, implying the initial association was not causal and was more likely due to unknown genetic or environmental factors.
Most women with lupus whose disease is not very active will have a safe pregnancy, new research concludes. The study also identified several risk factors that might put some women with systemic lupus erythematosus at higher risk for bad outcomes in pregnancy.
Researchers have identified two proteins in a fetus’ lungs responsible for initiating the labor process, providing potential new targets for preventing preterm birth. They discovered that the proteins SRC-1 and SRC-2 activate genes inside the fetus’ lungs near full term, leading to an inflammatory response in the mother’s uterus that initiates labor.
Washington, DC — Although roughly half of female marijuana users continue to use during pregnancy, evidence suggests that the drug may have a negative impact on fetal neurodevelopment. This is why in a Committee Opinion issued today, the American College of Obstetricians and Gynecologists (ACOG) is calling for ob-gyns to urge their patients who are pregnant or contemplating pregnancy to discontinue marijuana use.
SAN BRUNO, CA – June 8, 2015 –Cord Blood Registry® (CBR®), the world’s largest newborn stem cell company, today announced the launch of CBR’s Family Health Registry, a unique registry designed to offer insight into common diseases and conditions affecting families and to bring patients, healthcare professionals and researchers together to expedite and facilitate research related to the discovery of stem cell treatments and potential cures.
The registry serves as an extension to CBR’s Newborn Possibilities Program®, which uses health history screening to identify families who may benefit from cord blood banking and offers free newborn stem cell processing and storage for five years to families with a qualifying medical need. To date, the Newborn Possibilities Program has enrolled more than 6,000 families, storing newborn stem cells for at–risk individuals, releasing more than 70 units for therapeutic use, and connecting patients to FDA–approved autologous cord blood clinical trials.
Profiled health data from family respondents is already yielding valuable information. For example, based on recent survey data, although CBR’s clients are relatively young, a surprisingly high number of families
(approximately 1 in 7) have at least one indicated condition that might benefit from stem cell transplantation and/or potentially from the use of autologous or related allogeneic stem cells in regenerative medicine therapies.
“The combination of individual medical and familial information in an accessible database will empower families interested in preventing illness or reducing risk of disease. It will also help researchers develop insights that may improve outcomes and uses of novel technologies including those using stem cells,” said Paul Billings, MD, PhD, chief medical officer of Omicia, and former founder of CBR.
The most common transplant indications reported among first-degree family members were:
- Non-Hodgkin’s Lymphoma (18.9 percent)
- Hodgkin’s Lymphoma (17.7 percent)
- Acute Lymphoblastic Leukemia (16.2 percent)
- Sarcoma (8.1 percent)
- Acute Myelogenous Leukemia (6.5 percent)
- Sickle Cell Disease (5.7 percent)
The most common regenerative indications among children with stored umbilical cord blood were:
- Autism/Autism Spectrum Disorder/Apraxia (37.2 percent)
- Other Developmental Delay (26.5 percent)
- Congenital Heart Defect (15.8 percent)
- Childhood Hearing Loss (8.2 percent)
- Type I Diabetes (5.3 percent)
- Cerebral Palsy (4.9 percent)
Current trials in the U.S. are studying regenerative uses of umbilical cord blood stem cells for a wide variety of conditions including:
- Cerebral Palsy – Approximately 8,000 to 10,000 babies born in the U.S. each year will develop cerebral palsy (Source: CerebralPalsy.org)
- Ischemic/Hypoxic Brain Injury – Approximately 20 out of every 1,000 full term births and 60 percent of all premature births in the U.S. are affected by Ischemic/Hypoxic Brain Injury (Source:Cerebralpalsy.org)
- Autism – Approximately 58,000 children are diagnosed with autism each year in the U.S. (Source: CDC)
- Acquired Hearing Loss – Approximately 12,000 babies born each year in the U.S. have hearing loss (Source: Boston Children’s Hospital/NIH)
- Hypoplastic Left Heart Syndrome – Over 900 babies in the U.S. each year are born with Hypoplastic Left Heart Syndrome (Source: CDC)
Tel: (415) 318-4262
Cord Blood Registry
Tel: (650) 922-6603